Follow us...


Search News Archives





View Channel

Laboratory Products



View Channel

Special Offers and Promotions


Microscopy | Image Analysis



View Channel

Separation Science



View Channel

Coronavirus (COVID-19)



View Channel

Research & Case Studies



View Channel

Brochures & Literature



View Channel


Conferences | Events

Registration now live for SMi’s 12th annual Asthma & COPD conference and exhibition

publication date: Jan 20, 2016
author/source: SMi Group Ltd

SMi Group Reports: Its 12th annual conference on Asthma & COPD will be held in London on the 11th - 12th April 2016.

Asthma & COPD conferenceRespiratory diseases represent an enormous and increasing healthcare and economic burden across Europe and USA. Over the last few years, significant improvements in the management of asthma and COPD have been made, owing to new drugs, strategies and to the development of the nonpharmacologic treatment of COPD. Nevertheless, there are still many unmet needs in the treatment of these diseases.

The conference will explore innovative asthma and COPD drug development programmes, directives and procedures which have been put in place to reduce the enormous suffering from lung disease and its high mortality.

Keynote speakers for 2016 include:

  • (Chairman) - Ewan Walters, Medical Director, Teva UK
  • Peter Daley-Yates, Director Clinical Pharmacology, GSK
  • Andy Kenwright, Senior Statistical Scientist, Roche Pharma
  • Jan Olof Svensson, Principal Scientist, AstraZeneca
  • Roland Kolbeck, Senior Director, MedImmune
  • Nayna Govind, Director for the Development of Generic Inhalation Products, Dr. Reddy's Laboratories
  • Konstantinos Kostikas, Medical Director Respiratory, Novartis

For more information, to review the full agenda or to register please visit the event website


Highlights of Asthma & COPD 2016 include:

  • Discuss the challenges for generic inhalation products for EU and US markets
  • Gain insight into scientific aspects of quality regulations in respiratory drug development
  • Review innate lymphocytes (ILC) in COPD
  • Learn about "first in class" inhaled drugs for the treatment of COPD and cystic fibrosis
  • Explore corticosteroid insensitivity in severe asthma
  • Study formulation and process of inhaled products
  • Analyse clinical development of generic

In addition to the conference, the event will feature 2 interactive half-day post-conference workshops held on the 13th April 2016.
1. Human factors and inhaler handling studies
Workshop Leader: Stefan Leiner, Chemical - Pharmaceutical Expert, Boehringer Ingelheim

2. Pragmatic compliance remediation - how to get your marketed product into shape?
Workshop Leader: Mark Chipperfield, Principal Consultant, Corvus Device Limited

For delegate enquiries contact Matthew Apps +44 (0) 20 7827 6093  For sponsorship opportunities contact Alia Malick on +44 (0) 20 7827 6168.



If you have not logged into the website then please enter your details below.


Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin


Request your free copies HERE




Popular this Month...

Our Top 10 most popular articles this month


Today's Picks...




Looking for a Supplier?

Search by company or by product


Company Name:






Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


Media Partners